Promise of antisense oligodeoxynucleotide-based therapy for bladder cancer

Expert Rev Anticancer Ther. 2008 Dec;8(12):1851-4. doi: 10.1586/14737140.8.12.1851.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Oligonucleotides, Antisense / therapeutic use*
  • Point Mutation
  • Urinary Bladder Neoplasms / drug therapy*
  • Urinary Bladder Neoplasms / genetics

Substances

  • Oligonucleotides, Antisense